The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.
The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...
When pain signals are passed along the nervous system, proteins called calcium channels play a key role. Researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback